Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2012, Article ID 385978, 7 pages
http://dx.doi.org/10.1155/2012/385978
Review Article

Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials

1Division of Surgical Oncology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
2Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
3Department of Human Pathology, Integrated Therapies in Oncology Unit, University of Messina, 98125 Messina, Italy
4Division of Hematology/Oncology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA

Received 18 July 2011; Revised 13 October 2011; Accepted 13 October 2011

Academic Editor: Quyen D. Chu

Copyright © 2012 Keith D. Amos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [21 citations]

The following is the list of published articles that have cited the current article.

  • Neal P. Christiansen, Lei Chen, James Gilmore, and Stephen Szabo, “Cancer recurrence and survival in patients with early-stage triple-negative breast cancer,” Community Oncology, vol. 9, no. 6, pp. 182–187, 2012. View at Publisher · View at Google Scholar
  • Suthat Chottanapund, Majorie B.M. Van Duursen, Panida Navasumrit, Potchanee Hunsonti, Supatchaya Timtavorn, Mathuros Ruchirawat, and Martin Van den Berg, “Effect of androgens on different breast cancer cells co-cultured with or without breast adipose fibroblasts,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 138, pp. 54–62, 2013. View at Publisher · View at Google Scholar
  • T. M. A. Abdel-Fatah, C. Perry, P. Dickinson, G. Ball, P. Moseley, S. Madhusudan, I. O. Ellis, and S. Y. T. Chan, “Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings,” Annals of Oncology, vol. 24, no. 11, pp. 2801–2807, 2013. View at Publisher · View at Google Scholar
  • Arthur Adams, Aram S. A. van Brussel, Jeroen F. Vermeulen, Willem P. Th M. Mali, Elsken van der Wall, Paul J. van Diest, and Sjoerd G. Elias, “The potential of hypoxia markers as target for breast molecular imaging - a systematic review and meta-analysis of human marker expression,” Bmc Cancer, vol. 13, 2013. View at Publisher · View at Google Scholar
  • Nola Hylton, and Jade de Guzman, “Breast Magnetic Resonance Imaging for Monitoring Response to Therapy,” Magnetic Resonance Imaging Clinics Of North America, vol. 21, no. 3, pp. 533–+, 2013. View at Publisher · View at Google Scholar
  • Yi-Wen Chang, Mien-Chie Hung, and Jen-Liang Su, “The Anti-Tumor Activity of E1A and its Implications in Cancer Therapy,” Archivum Immunologiae et Therapiae Experimentalis, vol. 62, no. 3, pp. 195–204, 2014. View at Publisher · View at Google Scholar
  • Robert Schmadeka, and Bryan E. Harmon, “Triple-Negative Breast Carcinoma Current and Emerging Concepts,” American Journal of Clinical Pathology, vol. 141, no. 4, pp. 462–477, 2014. View at Publisher · View at Google Scholar
  • Jade de Guzman, Dragana Bogdanovic-Stojanovic, Dragana Djilas, and Haydee Ojeda-Fournier, “Preoperative Breast Cancer Evaluation and Advanced Breast Cancer Imaging,” Women's Imaging, pp. 296–321, 2014. View at Publisher · View at Google Scholar
  • Prasanth Ganesan, Stacy Moulder, J. Jack Lee, Filip Janku, Vicente Valero, Ralph G. Zinner, Aung Naing, Siqing Fu, Apostolia M. Tsimberidou, David Hong, Bettzy Stephen, Philip Stephens, Roman Yelensky, Funda Meric-Bernstam, Razelle Kurzrock, and Jennifer J. Wheler, “Triple-Negative Breast Cancer Patients Treated at MD Anderson Cancer Center in Phase I Trials: Improved Outcomes with Combination Chemotherapy and Tar,” Molecular Cancer Therapeutics, vol. 13, no. 12, pp. 3175–3184, 2014. View at Publisher · View at Google Scholar
  • Diego J. Martinel Lamas, Jorge E. Cortina, Clara Ventura, Helena A. Sterle, Eduardo Valli, Karina B. Balestrasse, Horacio Blanco, Graciela A. Cremaschi, Elena S. Rivera, and Vanina A. Medina, “Enhancement of Ionizing Radiation Response by Histamine in Vitro and in Vivo in Human Breast Cancer,” Cancer Biology & Therapy, pp. 00–00, 2014. View at Publisher · View at Google Scholar
  • R. Zhou, L. Xu, M. Ye, M. Liao, H. Du, and H. Chen, “Formononetin Inhibits Migration and Invasion of MDA-MB-231 and 4T1 Breast Cancer Cells by Suppressing MMP-2 and MMP-9 Through PI3K/AKT Signaling Pathways,” Hormone and Metabolic Research, vol. 46, no. 11, pp. 753–760, 2014. View at Publisher · View at Google Scholar
  • Elena Geretti, Shannon Curtis Leonard, Nancy Dumont, Helen Lee, Jinzi Zheng, Raquel De Souza, Daniel F. Gaddy, Christopher W. Espelin, David A. Jaffray, Victor Moyo, Ulrik B. Nielsen, Thomas J. Wickham, and Bart S. Hendriks, “Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302),” Molecular Cancer Therapeutics, vol. 14, no. 9, pp. 2060–2071, 2015. View at Publisher · View at Google Scholar
  • Hanan Ahmed Wahba, and Hend Ahmed El-Hadaad, “Current approaches in treatment of triple-negative breast cancer.,” Cancer biology & medicine, vol. 12, no. 2, pp. 106–16, 2015. View at Publisher · View at Google Scholar
  • Xi Gu, Yang Zhang, Long Chen, Jiao Guo, and Wen-Hai Zhang, “Efficacy of neo-adjuvant chemotherapy with TEC regimen on breast cancer,” Cancer Chemotherapy And Pharmacology, vol. 75, no. 2, pp. 301–308, 2015. View at Publisher · View at Google Scholar
  • Fan Zeng, Wan-Liang Lu, Rui-Jun Ju, Lei Liu, Hong-Jun Xie, Li-Min Mu, Yao Zhao, Yan Yan, Ying-Jie Hu, and Jia-Shuan Wu, “Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer.,” Oncotarget, vol. 6, no. 34, pp. 36625–42, 2015. View at Publisher · View at Google Scholar
  • Zhiying Shao, Shalini Chaudhri, Meng Guo, Longzhen Zhang, and Daniel Rea, “Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study,” Oncology Research, vol. 23, no. 6, pp. 291–302, 2016. View at Publisher · View at Google Scholar
  • Xiaomeng Tang, Welley S Loc, Cheng Dong, Gail L Matters, Peter J Butler, Mark Kester, Craig Meyers, Yixing Jiang, and James H Adair, “The use of nanoparticulates to treat breast cancer,” Nanomedicine, 2017. View at Publisher · View at Google Scholar
  • Ryuji Ohashi, Maoka Sangen, Shigeki Namimatsu, Keiko Yanagihara, Koji Yamashita, Takashi Sakatani, Hiroyuki Takei, and Zenya Naito, “Prognostic value of IMP3 expression as a determinant of chemosensitivity in triple-negative breast cancer,” Pathology - Research and Practice, 2017. View at Publisher · View at Google Scholar
  • W H Lee, L Y Choong, T H Jin, N N Mon, S Chong, C S Liew, T Putti, S Y Lu, C Harteneck, and Y P Lim, “TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein,” Oncogenesis, vol. 6, no. 5, pp. e338, 2017. View at Publisher · View at Google Scholar
  • Aurelio Bartolome Castrellon, Ihor Pidhorecky, Vicente Valero, and Luis Estuardo Raez, “The Role of Carboplatin in the Neoadjuvant Chemotherapy Treatment of Triple Negative Breast Cancer.,” Oncology reviews, vol. 11, no. 1, pp. 324, 2017. View at Publisher · View at Google Scholar
  • Chao Wang, Shreya Kar, Xianning Lai, Wanpei Cai, Frank Arfuso, Gautam Sethi, Peter E. Lobie, Boon C. Goh, Lina H.K. Lim, Mikael Hartman, Ching W. Chan, Soo C. Lee, Sing H. Tan, and Alan P. Kumar, “Triple Negative Breast Cancer in Asia: An Insider’s View,” Cancer Treatment Reviews, 2017. View at Publisher · View at Google Scholar